English | Español
Patient Daily | Mar 25, 2026

American Lung Association comments on decline in adult smoking rates and tobacco use trends
Patient Daily | Mar 25, 2026

BioSpace reports nearly 1,000 clinical job openings at 11 companies in March
Patient Daily | Mar 25, 2026

Recruiters outline six common mistakes biopharma job seekers should avoid
Patient Daily | Mar 25, 2026

AstraZeneca announces Shanghai cell therapy manufacturing base to support China strategy
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
Patient Daily | Mar 25, 2026

FDA approves higher dose of Wegovy for weight loss under priority voucher program
Patient Daily | Mar 25, 2026

Opinion piece discusses challenges in ALS drug development and calls for policy changes
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug